Finance

Lists
Why is MGRX down 4,37%?
Dive Deeper
MGRX:NASDAQ
Mangoceuticals Inc
0,42 USD
-4,37%
(-0,019) 1D
0,41 USD
-1,75% (-0,0073)
Pre-market
Closed: 5-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGRX...
Open
0,43 USD
High
0,44 USD
Low
0,41 USD
Mkt. cap
8,96 млн
Avg. vol.
590,66 миң
Volume
12,36 миң
52-wk high
2,75 USD
52-wk low
0,16 USD
EPS
-1,19 USD
Beta
1,98
Shares outstanding
21,57 млн
No. of employees
3
Open
0,43 USD
High
0,44 USD
Low
0,41 USD
Mkt. cap
8,96 млн
Avg. vol.
590,66 миң
Volume
12,36 миң
52-wk high
2,75 USD
52-wk low
0,16 USD
EPS
-1,19 USD
Beta
1,98
Shares outstanding
21,57 млн
No. of employees
3
News stories
From web sources and news partners
About Mangoceuticals Inc
CEO-
Employees3
Founded2021
HeadquartersДаллас, Техас, Америка Кошмо Штаттары
SectorDrug
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
84,25 миң
94,36 миң
67,86 миң
68,76 миң
Cost of goods sold
33,35 миң
46,88 миң
38,86 миң
24,54 миң
Cost of revenue
33,35 миң
46,88 миң
38,86 миң
24,54 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
958,71 миң
385,80 миң
1,50 млн
984,84 миң
Operating expense
7,56 млн
1,53 млн
3,14 млн
1,08 млн
Total operating expenses
7,59 млн
1,58 млн
3,18 млн
1,10 млн
Operating income
-7,51 млн
-1,49 млн
-3,11 млн
-1,03 млн
Other non operating income
-33,32 миң
-2,89 миң
-12,45 миң
-
EBT including unusual items
-7,62 млн
-2,77 млн
-3,40 млн
-1,31 млн
EBT excluding unusual items
-7,62 млн
-1,51 млн
-3,40 млн
-1,31 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,62 млн
-2,77 млн
-3,40 млн
-1,31 млн
Net profit margin
-9 042,82%
-2 935,11%
-5 014,66%
-1 909,12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-75,85 миң
-19,66 миң
-276,82 миң
-279,89 миң
Net interest expenses
-75,85 миң
-19,66 миң
-276,82 миң
-279,89 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,48 млн
-1,04 млн
-2,82 млн
-738,21 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору